Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Asia-Pacific Journal of Clinical Oncology
|
March 22, 2016
Indigenous Australians with non-small cell lung cancer or cervical cancer receive suboptimal treatment
Lisa J Whop, Christina M Bernardes, Srinivas Kondalsamy-Chennakesavan, et al.
NPJ Precision Oncology
|
December 7, 2023
Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibition
Asmerom T Sengal, Vanessa Bonazzi, Deborah Smith, et al.
Gynecologic Oncology
|
February 28, 2012
Nomograms to predict isolated loco-regional or distant recurrence among women with uterine cancer
Srinivas Kondalsamy-Chennakesavan, Changhong Yu, Michael W Kattan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 30, 2020
Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer
Shih-Ern Yao, Lee Tripcony, Karen Sanday, et al.
Gynecologic Oncology
|
April 2, 2015
Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial
Jannah Baker, Monika Janda, Nick Graves, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology
|
July 19, 2017
The shift toward neo-adjuvant chemotherapy and interval debulking surgery for management of advanced ovarian and related cancers in a population-based setting: Impact on clinical outcomes
James L Nicklin, Shaun McGrath, Lee Tripcony, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology
|
June 1, 2023
Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high-grade serous ovarian, fallopian tube, peritoneal cancer in an Australian context
Arthur Samoylovich, Bronwyn Jennings, Catherine Shannon, et al.
Biomaterials
|
August 11, 2019
Microenvironment engineering of osteoblastic bone metastases reveals osteomimicry of patient-derived prostate cancer xenografts
Ali Shokoohmand, Jiongyu Ren, Jeremy Baldwin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 10, 2025
Antigen presentation potential is variable among human ovarian tumour and syngeneic murine models and dictates pre-clinical outcomes of immunotherapy
Louisa Alim, Siddharth Adityan, Rui Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 23, 2026
Scalable Engineering of Bio-Manufactured Extracellular Vesicles for Selective Delivery in Ovarian Cancer Patient-Derived Models
Nihar Godbole, Andrew Lai, Alexander Quinn, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Asia-Pacific Journal of Clinical Oncology
|
March 22, 2016
Indigenous Australians with non-small cell lung cancer or cervical cancer receive suboptimal treatment
Lisa J Whop, Christina M Bernardes, Srinivas Kondalsamy-Chennakesavan, et al.
NPJ Precision Oncology
|
December 7, 2023
Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibition
Asmerom T Sengal, Vanessa Bonazzi, Deborah Smith, et al.
Gynecologic Oncology
|
February 28, 2012
Nomograms to predict isolated loco-regional or distant recurrence among women with uterine cancer
Srinivas Kondalsamy-Chennakesavan, Changhong Yu, Michael W Kattan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 30, 2020
Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer
Shih-Ern Yao, Lee Tripcony, Karen Sanday, et al.
Gynecologic Oncology
|
April 2, 2015
Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial
Jannah Baker, Monika Janda, Nick Graves, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology
|
July 19, 2017
The shift toward neo-adjuvant chemotherapy and interval debulking surgery for management of advanced ovarian and related cancers in a population-based setting: Impact on clinical outcomes
James L Nicklin, Shaun McGrath, Lee Tripcony, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology
|
June 1, 2023
Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high-grade serous ovarian, fallopian tube, peritoneal cancer in an Australian context
Arthur Samoylovich, Bronwyn Jennings, Catherine Shannon, et al.
Biomaterials
|
August 11, 2019
Microenvironment engineering of osteoblastic bone metastases reveals osteomimicry of patient-derived prostate cancer xenografts
Ali Shokoohmand, Jiongyu Ren, Jeremy Baldwin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 10, 2025
Antigen presentation potential is variable among human ovarian tumour and syngeneic murine models and dictates pre-clinical outcomes of immunotherapy
Louisa Alim, Siddharth Adityan, Rui Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 23, 2026
Scalable Engineering of Bio-Manufactured Extracellular Vesicles for Selective Delivery in Ovarian Cancer Patient-Derived Models
Nihar Godbole, Andrew Lai, Alexander Quinn, et al.
Page
of 4